Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE.

Zweegers, J; van den Reek, J M P A; van de Kerkhof, P C M; Otero, M E; Ossenkoppele, P M; Njoo, M D; Mommers, J M; Koetsier, M I A; Arnold, W P; Sybrandy-Fleuren, B A M; Kuijpers, A L A; Andriessen, M P M; Kievit, W; de Jong, E M G J

Zweegers, J; van den Reek, J M P A; van de Kerkhof, P C M; Otero, M E; Ossenkoppele, P M; Njoo, M D; Mommers, J M; Koetsier, M I A; Arnold, W P; Sybrandy-Fleuren, B A M; Kuijpers, A L A; Andriessen, M P M; Kievit, W; de Jong, E M G J.

Affiliation

Zweegers J; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, René Descartesdreef 1, Nijmegen, 6525 GL, the Netherlands.

Br J Dermatol ; 171(5): 1091-8, 2014 Nov.

Article in En | MEDLINE | ID: mdl-24861358

Subject(s)

Biological Factors/therapeutic use; Dermatologic Agents/therapeutic use; Psoriasis/drug therapy; Adalimumab; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Decision Making; Drug Substitution; Drug Therapy, Combination; Etanercept; Female; Goals; Humans; Immunoglobulin G/therapeutic use; Infliximab; Male; Middle Aged; Prospective Studies; Quality of Life; Receptors, Tumor Necrosis Factor/therapeutic use; Ustekinumab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Factors / Dermatologic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2014 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google